Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma

Leukemia and Lymphoma

Volumn 48, Issue 3, 2007, Pages 564-569

  Hohaus, Stefan ^a   Mansueto, Giovanna ^a   Massini, Giuseppina ^a   D'Alo, Francesco ^a   Giachelia, Manuela ^a   Martini, Maurizio ^a   Larocca, Luigi Maria ^a   Voso, Maria Teresa ^a   Leone, Giuseppe ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Follicular NHL; Genetic susceptibility; GST; Polymorphism; Prognostic factors

Indexed keywords

BLEOMYCIN; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FOLINIC ACID; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; PREDNISONE; RITUXIMAB; VALINE; VINCRISTINE;

ADULT; AGED; ARTICLE; CANCER GRADING; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME POLYMORPHISM; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GENE DELETION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE DELETION; GENOTYPE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS;

EID: 33947665054     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190601158647     Document Type: Article

References (37)

1. (1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: The non-Hodgkin's lymphoma classification project. Blood, 89, pp. 3909-3918.
2. Rohatiner, A. Z. and Lister, T. A. (2005) The clinical course of follicular lymphoma. Best Pract Res Clin Haematol, 18, pp. 1-10.
3. Solal-Celigny, P., Roy, P., Colombat, P., White, J., Armitage, J. O. and Arranz-Saez, R. (2004) Follicular lymphoma international prognostic index. Blood, 104, pp. 1258-1265.
4. Schuler, F., Hirt, C. and Dolken, G. (2003) Chromosomal translocation t(14;18) in healthy individuals. Semin Cancer Biol, 13, pp. 203-209.
5. Viardot, A., Barth, T. F., Moller, P., Dohner, H. and Bentz, M. (2003) Cytogenetic evolution of follicular lymphoma. Semin Cancer Biol, 13, pp. 183-190.
6. de Jong, D. (2005) Molecular pathogenesis of follicular lymphoma: A cross talk of genetic and immunologic factors. J Clin Oncol, 23, pp. 6358-6363.
7. Dave, S. S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R. D. and Chan, W. C. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med, 351, pp. 2159-2169.
8. Glas, A. M., Kersten, M. J., Delahaye, L JMJ, Witteveen, A. T., Kibbelaar, R. E. and Velds, A. (2005) Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood, 105, pp. 301-307.
9. Strange, R. C., Jones, P. W. and Fryer, A. A. (2000) Glutathione S-transferase: Genetics and role in toxicology. Toxicol Lett, 112113, pp. 357-363.
10. McIlwain, C. C., Townsend, D. M. and Tew, K. D. (2006) Glutathione S-transferase polymorphisms: Cancer incidence and therapy. Oncogene, 25, pp. 1639-1648.
11. Seidegard, J., Vorachek, W. R., Pero, R. W. and Pearson, W. R. (1988) Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci USA, 85, pp. 7293-7297.
12. Pemble, S., Schroeder, K. R., Spencer, S. R., Meyer, D. J., Hallier, E. and Bolt, H. M. (1994) Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J, 300, pp. 271-276.
13. Ahmad, H., Wilson, D. E., Fritz, R. R., Singh, S. V., Medh, R. D. and Nagle, G. T. (1990) Primary and secondary structural analyses of glutathione S-transferase pi from human placenta. Arch Biochem Biophys, 278, pp. 398-408.
14. Watson, M. A., Stewart, R. K., Smith, G. B., Massey, T. E. and Bell, D. A. (1998) Human glutathione S-transferase P1 polymorphisms: Relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis, 19, pp. 275-280.
15. Jemth, P. and Mannervik, B. (1997) Kinetic characterization of glutathione transferase T1-1, a polymorphic detoxication enzyme. Arch Biochem Biophys, 348, pp. 247-254.
16. Rollinson, S., Roddam, P., Kane, E., Roman, E., Cartwright, R. and Jack, A. (2000) Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis, 21, pp. 43-47.
17. D'Alo, F., Voso, M. T., Guidi, F., Massini, G., Scardocci, A. and Sica, S. (2004) Polymorphisms of CYP1A1 and glutathione S-transferase and susceptibility to adult acute myeloid leukemia. Haematologica, 89, pp. 664-670.
18. Hohaus, S., Massini, G., D'Alo, F., Guidi, F., Putzulu, R. and Scardocci, A. (2003) Association between glutathione S-transferase genotypes and Hodgkin's lymphoma risk and prognosis. Clin Cancer Res, 9, pp. 3435-3440.
19. Rollinson, S., Levene, A. P., Mensah, F. K., Roddam, P. L., Allan, J. M. and Diss, T. C. (2003) Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood, 102, pp. 1007-1011.
20. Yuille, M., Condie, A., Hudson, C., Kote-Jarai, Z., Stone, E. and Eeles, R. (2002) Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Blood, 99, pp. 4216-4218.
21. Kerridge, I., Lincz, L., Scorgie, F., Hickey, D., Granter, N. and Spencer, A. (2002) Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk. Br J Haematol, 118, pp. 477-481.
22. Lemos, M. C., Cabrita, F. J., Silva, H. A., Vivan, M., Placido, F. and Regateiro, F. J. (1999) Genetic polymorphism of CYP2D6, GSTM1 and NAT2 and susceptibility to haematological neoplasias. Carcinogenesis, 20, pp. 1225-1229.
23. Sarmanova, J., Benesova, K., Gut, I., Nedelcheva-Kristensen, V., Tynkova, L. and Soucek, P. (2001) Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet, 10, pp. 1265-1273.
24. Chiu, B. C., Kolar, C., Gapstur, S. M., Lawson, T., Anderson, J. R. and Weisenburger, D. D. (2005) Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: A population-based case-control study. Br J Haematol, 128, pp. 610-615.
25. Ambrosone, C. B., Sweeney, C., Coles, B. F., Thompson, P. A., McClure, G. Y. and Korourian, S. (2001) Polymorphisms in Glutathione S-Transferases (GSTM1 and GSTT1) and Survival after Treatment for Breast Cancer. Cancer Res, 61, pp. 7130-7135.
26. Stanulla, M., Schrappe, M., Brechlin, A. M., Zimmermann, M. and Welte, K. (2000) Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: A case-control study. Blood, 95, pp. 1222-1228.
27. Voso, M. T., D'Alo, F., Putzulu, R., Mele, L., Scardocci, A. and Chiusolo, P. (2002) Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood, 100, pp. 2703-2707.
28. Sweeney, C., Nazar-Stewart, V., Stapleton, P. L., Thompson, P. A., McClure, G. Y. and Korourian, S. (2003) Glutathione S-transferase M1, T1, and P1 polymorphisms and survival among lung cancer patients. Cancer Epidemiol Biomarkers Prev, 12, pp. 527-533.
29. Fisher, R. I., Gaynor, E. R., Dahlberg, S., Oken, M. M., Grogan, T. M. and Mize, E. M. (1993) Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med, 328, pp. 1002-1006.
30. Zinzani, P. L., Storti, S., Zaccaria, A., Moretti, L., Magagnoli, M. and Pavone, E. (1999) Elderly aggressive-histology non-Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients. Blood, 94, pp. 33-38.
31. Tarella, C., Caracciolo, D., Corradini, P., Zallio, F., Ladetto, M. and Cuttica, A. (2000) Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft. Leukemia, 14, pp. 740-747.
32. Harries, L. W., Stubbins, M. J., Forman, D., Howard, G. C. and Wolf, C. R. (1997) Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis, 18, pp. 641-644.
33. Hohaus, S., Ruscio, A Di, Febo, A Di, Massini, G., D'Alo, F. and Guidi, F. (2005) Glutathione-S-transferase (GST) P1 genotype and prognosis in Hodgkin's lymphoma. Clin Cancer Res, 11, pp. 2175-2179.
34. Cheson, B. D., Horning, S. J., Coiffier, B., Shipp, M. A., Fisher, R. I. and Connors, J. M. (1999) Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. J Clin Oncol, 17, pp. 1244-1253.
35. Dieckvoss, B. O., Stanulla, M., Schrappe, M., Beier, R., Zimmermann, M. and Welte, K. (2002) Polymorphisms within glutathione S-transferase genes in pediatric non-Hodgkin's lymphoma. Haematologica, 87, pp. 709-713.
36. Takanashi, M., Morimoto, A., Yagi, T., Kuriyama, K., Kano, G. and Imamura, T. (2003) Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia. Haematologica, 88, pp. 1238-1244.
37. Matsuzoe, D., Hideshima, T., Iwasaki, A., Yoneda, S., Kawahara, K. and Shirakusa, T. (2001) Glutathione S-Transferase mu1 null genotype is associated with K-ras gene mutation in lung adenocarcinoma among smokers. Carcinogenesis, 22, pp. 1327-1330.